4.04% 1.25

Tg Therapeutics Inc (TGTX)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt TGTX? Forum Prognose Aktiensplit

Finanzdaten der Tg Therapeutics Inc-Aktie (TGTX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	44.35% 63.47	43.97	165.81	16.07	7.803
Cost Of Revenue	30.72% 5.441	7.854	3.509	-	-
Gross Profit	60.68% 58.03	36.12	162.31	-	-
Operating Expenses	38.48% 67.30	48.60	47.52	60.75	44.80
Interest Income/Expense	5.88% 2.288	2.431	3.713	3.627	2.844
Benefits Costs and Expenses	15.81% 74.15	64.03	51.03	63.68	47.03
Costs And Expenses	28.85% 72.74	56.46	51.03	63.68	47.03
Operating Income/Loss	25.75% -9.27	-12.48	114.78	-44.67	-36.99
Nonoperating Income/Loss	8.63% -1.408	-1.541	-0.854	-2.936	-2.24
Income/Loss From Continuing Operations Before Tax	46.76% -10.68	-20.06	114.78	-47.61	-39.23
Income Tax Expense/Benefit	0.029	-	-	-	-
Income/Loss From Continuing Operations After Tax	25.73% -10.71	-14.42	113.93	-47.61	-39.23
Net Income/Loss	25.73% -10.71	-14.42	113.93	-47.61	-39.23
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	38,042% 146.21	0.3833	142.87	141.50	140.31
Basic Earnings Per Share	30.00% -0.07	-0.10	0.80	-0.34	-0.28
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$17.87

2.88%

INCY

$68.84

2.65%

MRNA

$39.39

0.43%

UTHR

$359.58

0.16%

BGNE

$176.50

1.02%

BNTX

$113.08

1.56%